Validity of diagnostic codes and liver‐related laboratory abnormalities to identify hepatic decompensation events in the Veterans Aging Cohort Study
- 27 May 2011
- journal article
- research article
- Published by Wiley in Pharmacoepidemiology and Drug Safety
- Vol. 20 (7), 689-699
- https://doi.org/10.1002/pds.2148
Abstract
Purpose The absence of validated methods to identify hepatic decompensation in cohort studies has prevented a full understanding of the natural history of chronic liver diseases and impact of medications on this outcome. We determined the ability of diagnostic codes and liver‐related laboratory abnormalities to identify hepatic decompensation events within the Veterans Aging Cohort Study (VACS). Methods Medical records of patients with hepatic decompensation codes and/or laboratory abnormalities of liver dysfunction (total bilirubin ≥ 5.0 g/dL, albumin ≤ 2.0 g/dL, INR ≥ 1.7) recorded 1 year before through 6 months after VACS entry were reviewed to identify decompensation events (i.e., ascites, spontaneous bacterial peritonitis, variceal hemorrhage, hepatic encephalopathy, hepatocellular carcinoma) at VACS enrollment. Positive predictive values (PPVs) of diagnostic codes, laboratory abnormalities, and their combinations for confirmed outcomes were determined. Results Among 137 patients with a hepatic decompensation code and 197 with a laboratory abnormality, the diagnosis was confirmed in 57 (PPV, 42%; 95%CI, 33%–50%) and 56 (PPV, 28%; 95%CI, 22%–35%) patients, respectively. The combination of any code plus laboratory abnormality increased PPV (64%; 95%CI, 47%–79%). One inpatient or ≥2 outpatient diagnostic codes for ascites, spontaneous bacterial peritonitis, or variceal hemorrhage had high PPV (91%; 95%CI, 77%–98%) for confirmed hepatic decompensation events. Conclusion An algorithm of 1 inpatient or ≥ 2 outpatient codes for ascites, peritonitis, or variceal hemorrhage has sufficiently high PPV for hepatic decompensation to enable its use for epidemiologic research in VACS. This algorithm may be applicable to other cohorts. Copyright © 2011 John Wiley & Sons, Ltd.Keywords
Funding Information
- National Institute of Allergy and Infectious Diseases (K01-AI070001)
- National Institute on Alcohol Abuse and Alcoholism (U10-AA13566)
This publication has 35 references indexed in Scilit:
- Management of adult patients with ascites due to cirrhosis: An updateHepatology, 2009
- Rapid fibrosis progression among HIV/hepatitis C virus-co-infected adultsAIDS, 2007
- Sensitivity of an AIDS Case-Finding AlgorithmMedical Care, 2004
- Testing, Referral, and Treatment Patterns for Hepatitis C Virus Coinfection in a Cohort of Veterans with Human Immunodeficiency Virus InfectionClinical Infectious Diseases, 2003
- The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: A long-term retrospective cohort studyHepatology, 2001
- Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL ConferenceJournal of Hepatology, 2001
- Three questions can detect hazardous drinkers.2001
- Incidence and consistency of antiretroviral use among HIV-infected medicaid beneficiaries with schizophrenia.Published by Physicians Postgraduate Press, Inc ,2001
- Hepatitis C is more severe in drug users with human immunodeficiency virus infectionJournal of Viral Hepatitis, 2000
- A prospective multicenter study of hepatocellular carcinoma in italian hemophiliacs with chronic hepatitis C. The Study Group of the Association of Italian Hemophilia Centers.1998